We then compared the mean methylation levels of gene promoters in R and NR patients, confirming that MLH1, ATM and FHIT were significantly differentially methylated in adenomas on the basis of the presence or not of lesion recurrence (Figure 2). This evidence concerns the gene MLH1 and adenoma.